Replies to post #27668 on Marker Therapeutics Inc (MRKR)

[Inoviorulez]

I could see the FDA being lenient possibly and allowing the phase 1/2 study to complete. Remember, they only showed the evaluable patients enrolled initially. The FDA might state to allow this trial to finish treating the rest of the patients and then depending upon data possibly gain conditional approval. That's my opinion. The FDA is a mixed bag so nobody knows 100% what it wants.